Iterum Therapeutics (ITRM) Other Non Operating Income (2017 - 2022)
Historic Other Non Operating Income for Iterum Therapeutics (ITRM) over the last 6 years, with Q4 2022 value amounting to $3.0 million.
- Iterum Therapeutics' Other Non Operating Income fell 1690.06% to $3.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $5.5 million, marking a year-over-year increase of 10895.28%. This contributed to the annual value of -$3.3 million for FY2024, which is 12956.77% down from last year.
- Latest data reveals that Iterum Therapeutics reported Other Non Operating Income of $3.0 million as of Q4 2022, which was down 1690.06% from -$4.8 million recorded in Q3 2022.
- Iterum Therapeutics' 5-year Other Non Operating Income high stood at $15.8 million for Q2 2021, and its period low was -$90.1 million during Q1 2021.
- Moreover, its 5-year median value for Other Non Operating Income was $92500.0 (2018), whereas its average is -$2.8 million.
- In the last 5 years, Iterum Therapeutics' Other Non Operating Income plummeted by 3450000.0% in 2020 and then surged by 13171666.67% in 2021.
- Iterum Therapeutics' Other Non Operating Income (Quarter) stood at $218000.0 in 2018, then plummeted by 103.67% to -$8000.0 in 2019, then tumbled by 34500.0% to -$2.8 million in 2020, then skyrocketed by 228.68% to $3.6 million in 2021, then dropped by 16.9% to $3.0 million in 2022.
- Its Other Non Operating Income stands at $3.0 million for Q4 2022, versus -$4.8 million for Q3 2022 and $2.2 million for Q2 2022.